# A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

> **NCT00879034** · PHASE2 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 5 (actual)

## Conditions studied

- Progeria
- Hutchinson-Gilford Syndrome

## Interventions

- **DRUG:** Lonafarnib
- **DRUG:** Zoledronic Acid
- **DRUG:** Pravastatin

## Key facts

- **NCT ID:** NCT00879034
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879034, "A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00879034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*